Within hours of stepping into office, newly inaugurated President Joe Biden froze a Trump era executive order that had been designed to lower the price of insulin.
“[T]his action temporarily delays for 60 days from the date of the memorandum the effective date of the final rule titled ‘Implementation of Executive Order on Access to Affordable Life-saving Medications,'” Biden’s Department of Health and Human Services announced via the Federal Register.
Note the name of the Trump-era rule.
Instituted last month, the rule mandated that community health centers which benefit from federal grants “establish practices to provide access to insulin and injectable epinephrine to low-income health center patients at the price the health center purchased these two drugs.”
Versus at a marked-up — or, allegedly, marked-down — price.
The rule’s freeze — which, to be clear, might conceivably be reversed once the delay period ends on March 22nd — has triggered anger from Americans, some of them doctors, who feel as if Biden is sticking it to those with diabetes for partisan reasons.
The Staff: Dirtbag Biden raises cost because President Trump tried to save the PEOPLE MONEY BUYING INSULIN
No comments:
Post a Comment